Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kartal Oksit is one of the leading Turkish manufacturers of zinc oxide established in 2002. The company specializes in producing high-quality zinc oxide using both indirect ("French") and direct ("American") methods. Its products are primarily used as raw materials across multiple industries such as rubber manufacturing, ceramics, glassmaking, paints/coatings, plastics compounding, animal feed additives—rather than pharmaceuticals or healthcare applications.[1][2][4] There is no evidence that it operates within life sciences/biotech/pharma/healthcare sectors or develops therapeutic products. The business is active with international import/export operations but does not have a public trading symbol nor notable partnerships within pharma/life sciences.[3][5][9]
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kartal Oksit.